Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitario Puerta de Hierro, IDIPHISA, Madrid, Spain; CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart, ERN GUARD-Heart, Amsterdam, the Netherlands.
European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart, ERN GUARD-Heart, Amsterdam, the Netherlands; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain; Health in Code, Madrid, Spain.
J Am Coll Cardiol. 2024 Apr 30;83(17):1640-1651. doi: 10.1016/j.jacc.2024.02.036.
Disease penetrance in genotype-positive (G+) relatives of families with dilated cardiomyopathy (DCM) and the characteristics associated with DCM onset in these individuals are unknown.
This study sought to determine the penetrance of new DCM diagnosis in G+ relatives and to identify factors associated with DCM development.
The authors evaluated 779 G+ patients (age 35.8 ± 17.3 years; 459 [59%] females; 367 [47%] with variants in TTN) without DCM followed at 25 Spanish centers.
After a median follow-up of 37.1 months (Q1-Q3: 16.3-63.8 months), 85 individuals (10.9%) developed DCM (incidence rate of 2.9 per 100 person-years; 95% CI: 2.3-3.5 per 100 person-years). DCM penetrance and age at DCM onset was different according to underlying gene group (log-rank P = 0.015 and P <0.01, respectively). In a multivariable model excluding CMR parameters, independent predictors of DCM development were: older age (HR per 1-year increase: 1.02; 95% CI: 1.0-1.04), an abnormal electrocardiogram (HR: 2.13; 95% CI: 1.38-3.29); presence of variants in motor sarcomeric genes (HR: 1.92; 95% CI: 1.05-3.50); lower left ventricular ejection fraction (HR per 1% increase: 0.86; 95% CI: 0.82-0.90) and larger left ventricular end-diastolic diameter (HR per 1-mm increase: 1.10; 95% CI: 1.06-1.13). Multivariable analysis in individuals with cardiac magnetic resonance and late gadolinium enhancement assessment (n = 360, 45%) identified late gadolinium enhancement as an additional independent predictor of DCM development (HR: 2.52; 95% CI: 1.43-4.45).
Following a first negative screening, approximately 11% of G+ relatives developed DCM during a median follow-up of 3 years. Older age, an abnormal electrocardiogram, lower left ventricular ejection fraction, increased left ventricular end-diastolic diameter, motor sarcomeric genetic variants, and late gadolinium enhancement are associated with a higher risk of developing DCM.
扩张型心肌病(DCM)患者的基因型阳性(G+)亲属中疾病的外显率以及这些个体中与 DCM 发病相关的特征尚不清楚。
本研究旨在确定 G+亲属中新诊断的 DCM 的外显率,并确定与 DCM 发生相关的因素。
作者评估了 25 家西班牙中心随访的 779 名 G+患者(年龄 35.8±17.3 岁;459 名[59%]女性;367 名[47%]携带 TTN 变异),这些患者均无 DCM。
中位随访 37.1 个月(Q1-Q3:16.3-63.8 个月)后,85 名患者(10.9%)发生 DCM(发病率为 2.9/100 人年;95%CI:2.3-3.5/100 人年)。根据潜在基因组,DCM 的外显率和发病年龄不同(对数秩检验 P=0.015 和 P<0.01)。在排除 CMR 参数的多变量模型中,DCM 发生的独立预测因素包括:年龄较大(每增加 1 岁的 HR:1.02;95%CI:1.0-1.04)、心电图异常(HR:2.13;95%CI:1.38-3.29)、运动肌节基因突变(HR:1.92;95%CI:1.05-3.50)、左心室射血分数较低(每增加 1%的 HR:0.86;95%CI:0.82-0.90)和左心室舒张末期直径较大(每增加 1mm 的 HR:1.10;95%CI:1.06-1.13)。对接受心脏磁共振和延迟钆增强评估的 360 名个体(45%)的多变量分析确定,延迟钆增强是 DCM 发生的另一个独立预测因素(HR:2.52;95%CI:1.43-4.45)。
在首次阴性筛查后,约 11%的 G+亲属在中位 3 年的随访中发生 DCM。年龄较大、心电图异常、左心室射血分数降低、左心室舒张末期直径增加、运动肌节基因突变和延迟钆增强与发生 DCM 的风险增加相关。